Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > 5 Turkish Sites Dosing
View:
Post by Viking2233 on Oct 14, 2024 7:51pm

5 Turkish Sites Dosing

At some point and time the markets will finally wake up and realize that Arch has been dosing at 5 sites for almost 8 months. We have no idea how many patients have been dosed but we know that there has been zero adverse reactions to the dosing. This is huge positive fact.

The other huge factor is they are dosing at 4x times  the previous phase 2 dosage, this could produce stellar results.

IMO they have most likely dosed 100+ patients.

Daily volume continues to struggle and now is the time for management to step up and start promoting the story. Management needs to start pounding the payment, spend some $$$ promoting this opportunity and drive new buyers to the market.

There are many aspects out of the  control of management but promoting the story is in their control and is their responsibility!

Good luck to all the longs!!
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities